• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Brooks-LaSure confirmed as CMS head


Biden’s pick becomes the first Black leader to head the agency.

Brooks-LaSure confirmed as CMS head

The Senate confirmed Chiquita Brooks-LaSure to head the Centers for Medicare & Medicaid Services (CMS) March 26 making her the first Black administrator to lead the agency.

The New York Times reports that five Republicans crossed the aisle to support Brooks-LaSure’s confirmation.

Brooks-LaSure previously served as a deputy director in a CMS office that oversaw health insurance markets, but before joining the administration she was already intimately familiar with the Affordable Care Act having worked on crafting parts of it as a health staffer with the House Ways and Means Committee, as previously reported.

Her time with that committee brought her into close contact with the new head of the Department of Health and Human Services Xavier Becerra who sat on that committee at the same time. Becerra was confirmed in an even tighter 50 to 49 vote in March after a contentious debate over his qualifications.

Axios reports that experts are concerned that President Joe R. Biden’s delay in nominating someone to lead the Food and Drug Administration as career staff hold off on making decisions until appointees are chosen or in place.

Related Videos
© drsampsondavis.com
© drsampsondavis.com
© drsampsondavis.com
© drsampsondavis.com
© drsampsondavis.com